New Enterprise Associates (NEA) led the equity funding, and additional investments were received from CVS Health Ventures, CapitalG, Echo Health Ventures, Town Hall Ventures and Redpoint, alongside several new institutional investors, including funds and accounts managed by affiliates of BlackRock, Inc.

新企业联合公司（NEA）领投了此次股权融资，CVS健康创投、CapitalG、回声健康创投、市政厅创投和红点创投等也进行了额外投资，同时还有一些新的机构投资者参与，包括由贝莱德集团（BlackRock, Inc.）关联公司管理的基金和账户。

Hercules Capital led the debt financing..

Hercules Capital 领衔了此次债务融资。

Strive Health is the nation's leader in value-based kidney care and partner of choice for innovative healthcare payors and providers. Using a unique combination of AI technology, care interventions and seamless integration with local providers, Strive forms an integrated care delivery system that supports the entire patient journey from chronic kidney disease (CKD) to end-stage kidney disease (ESKD).

Strive Health 是美国基于价值的肾脏护理领域的领导者，也是创新医疗支付方和供应商的首选合作伙伴。通过结合人工智能技术、护理干预以及与当地供应商的无缝整合，Strive 形成了一个综合护理交付系统，支持患者从慢性肾病 (CKD) 到终末期肾病 (ESKD) 的整个治疗过程。

To help patients, Strive partners with commercial and Medicare Advantage payors, Medicare, health systems and physicians through flexible value-based payment arrangements, including risk-based programs. Strive serves over 145,000 people with CKD and ESKD across 50 states and partners with over 6,500 providers.

为了帮助患者，Strive 与商业保险机构、Medicare Advantage支付方、Medicare、卫生系统及医生通过灵活的基于价值的支付安排（包括基于风险的项目）合作。Strive 在全美50个州为超过145,000名慢性肾病（CKD）和终末期肾病（ESKD）患者提供服务，并与6,500多家医疗服务提供者合作。

Strive's case management and population health programs are accredited by the National Committee for Quality Assurance (NCQA), and its technology platform, CareMultiplier™, is certified by HITRUST..

Strive的案例管理和群体健康项目获得了国家质量保证委员会（NCQA）的认可，其技术平台CareMultiplier™也通过了HITRUST的认证。